Active Filter(s):
Details:
MC16 is unique in that it is designed to be a gene-mutation agnostic treatment with the potential to treat all forms of RP.
Lead Product(s): MC16
Therapeutic Area: Genetic Disease Product Name: MC16
Highest Development Status: Undisclosed Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 14, 2021